Daniel L. Shawler

3.2k total citations
44 papers, 2.5k citations indexed

About

Daniel L. Shawler is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel L. Shawler has authored 44 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 20 papers in Oncology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel L. Shawler's work include Immunotherapy and Immune Responses (15 papers), Cancer Research and Treatments (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Daniel L. Shawler is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cancer Research and Treatments (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Daniel L. Shawler collaborates with scholars based in United States, Canada and Hungary. Daniel L. Shawler's co-authors include Robert O. Dillman, Habib Fakhrai, Ivor Royston, Richard M. Bartholomew, Leia M. Smith, Argyrios N. Theofilopoulos, Frank J. Dixon, Robert E. Sobol, Duane E. Johnson and John Nemunaitis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Daniel L. Shawler

44 papers receiving 2.4k citations

Peers

Countries citing papers authored by Daniel L. Shawler

Since Specialization

Citations

This map shows the geographic impact of Daniel L. Shawler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Shawler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Shawler more than expected).

Fields of papers citing papers by Daniel L. Shawler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Shawler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Shawler. The network helps show where Daniel L. Shawler may publish in the future.

Co-authorship network of co-authors of Daniel L. Shawler

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Shawler. A scholar is included among the top collaborators of Daniel L. Shawler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Shawler. Daniel L. Shawler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer 2015 ·European Journal of Cancer ·Giuseppe Giaccone, Lyudmila Bazhenova, John Nemunaitis, Ming Tan, Erzsébet Juhász, Rodryg Ramlau, Michel M. van den Heuvel, Rohit Lal, Goetz Kloecker, Keith D. Eaton, Quincy S. Chu, David J. Dunlop, Minish Jain, Edward B. Garon, Ch Davis, Ewa Carrier, (unknown), Daniel L. Shawler, Habib Fakhrai	199
2	The stability of breast cancer progenitor cells during cryopreservation: Maintenance of proliferation, self-renewal, and senescence characteristics 2010 ·Cryobiology ·Feridoun Karimi‐Busheri, (unknown), Daniel L. Shawler, Habib Fakhrai	14
3	Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients 2009 ·Cancer Gene Therapy ·John Nemunaitis, Michael Nemunaitis, Neil Senzer, (unknown), Cindi Bedell, Padmasini Kumar, Beena O. Pappen, Phillip B. Maples, Daniel L. Shawler, Habib Fakhrai	116
4	Phase I clinical trial of a TGF-β antisense-modified tumor cell vaccine in patients with advanced glioma 2006 ·Cancer Gene Therapy ·Habib Fakhrai, J. Mantil, Lei Liu, (unknown), (unknown), J. Michael Ruppert, Daniel L. Shawler	71
5	Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine 2002 ·Clinical & Experimental Immunology ·Daniel L. Shawler, Richard M. Bartholomew, (unknown), Richard Trauger, Oliver Dorigo, (unknown), Anna Marchese, F. Ferré, Colm R. Duffy, Dennis J. Carlo, Linda A. Sherman, Daniel P. Gold, Robert E. Sobol	18
6	Combination of Transforming Growth Factor β Antisense and Interleukin-2 Gene Therapy in the Murine Ovarian Teratoma Model 1998 ·Gynecologic Oncology ·Oliver Dorigo, Daniel L. Shawler, Ivor Royston, Robert E. Sobol, J. S. Berek, Habib Fakhrai	20
7	Gene Therapy Approaches to Enhance Antitumor Immunity 1997 ·Advances in pharmacology ·Daniel L. Shawler, Habib Fakhrai, Charles Van Beveren, Dan Mercola, Daniel P. Gold, Richard M. Bartholomew, Ivor Royston, Robert E. Sobol	8
8	Construction and Characterization of Retroviral Vectors for Interleukin-2 Gene Therapy 1997 ·Journal of Immunotherapy ·Habib Fakhrai, Daniel L. Shawler, Charles Van Beveren, Hong Lin, Oliver Dorigo, Michael J. Solomon, Ruth A. Gjerset, Larry Smith, Richard M. Bartholomew, César Boggiano, Daniel P. Gold, Robert E. Sobol	7
9	Cytokine Gene Therapy with Interleukin-2-Transduced Fibroblasts: Effects of IL-2 Dose on Anti-Tumor Immunity 1995 ·Human Gene Therapy ·Habib Fakhrai, Daniel L. Shawler, Ruth A. Gjerset, Robert K. Naviaux, James A. Koziol, Ivor Royston, Robert E. Sobol	63
10	Comparison of Gene Therapy with Interleukin-2 Gene Modified Fibroblasts and Tumor Cells in the Murine CT-26 Model of Colorectal Carcinoma 1995 ·Journal of Immunotherapy ·Daniel L. Shawler, Oliver Dorigo, Ruth A. Gjerset, Ivor Royston, Robert E. Sobol, Habib Fakhrai	20
11	Characterization of a new human glioblastoma cell line that expresses mutant P53 and lacks activation of the PDGF pathway 1995 ·In Vitro Cellular & Developmental Biology - Animal ·Ruth A. Gjerset, Habib Fakhrai, Daniel L. Shawler, Sally Turla, Oliver Dorigo, (unknown), Dan Mercola, Shu-Fen Wen, (unknown), Hong Lin, (unknown), Carol A. Kruse, Ivor Royston, Robert E. Sobol	9
12	Human Anti-Mouse Antibody Response in Cancer Patients Following Single Low-Dose Injections of Radiolabeled Murine Monoclonal Antibodies 1994 ·PubMed ·Robert O. Dillman, Daniel L. Shawler, (unknown), Samuel E. Halpern	28
13	Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101 1988 ·Clinical Immunology and Immunopathology ·Daniel L. Shawler, Duane E. Johnson, (unknown), Richard M. Bartholomew, (unknown)	15
14	Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug. 1988 ·PubMed ·Robert O. Dillman, Duane E. Johnson, Daniel L. Shawler, Jim Koziol	58
15	Serologic and cellular assays to monitor therapy with murine monoclonal antibodies 1987 ·Journal of Clinical Laboratory Analysis ·Daniel L. Shawler, (unknown), Robert E. Sobol, Robert O. Dillman	8
16	Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin. 1986 ·PubMed ·Robert O. Dillman, Daniel L. Shawler, Duane E. Johnson, Damon L. Meyer, James A. Koziol, James M. Frincke	52
17	The use of monoclonal antibodies and flow cytometry to detect peripheral blood and bone marrow involvement of a diffuse, poorly differentiated lymphoma 1985 ·International Journal of Immunopharmacology ·Daniel L. Shawler, Susan B. Wormsley, R O Dillman, Dennis M. Frisman, (unknown), Mark C. Glassy, Ivor Royston	4
18	Specificities of NZB anti-H-2d CML reactions: role of Qa-1 and retroviral gp70 antigens. 1981 ·The Journal of Immunology ·Argyrios N. Theofilopoulos, Daniel L. Shawler, Robert Balderas, John H. Elder, D H Katz, Frank J. Dixon	12
19	Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice. 1980 ·The Journal of Experimental Medicine ·Argyrios N. Theofilopoulos, Daniel L. Shawler, Robert A. Eisenberg, Frank J. Dixon	132
20	Patterns of immune reactivity in autoimmune murine strains. I. Cell-mediated immune responses induced by H-2 indentical and H-2 incompatible stimulator cells. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Argyrios N. Theofilopoulos, Daniel L. Shawler, David H. Katz, Frank J. Dixon	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact